维普期刊资源整合服务平台（V6.5）

82篇 您的检索式：作者名="FIGLIN R"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	The Usefulness of F-18 Deoxyglucose Whole-body Positron Emission Tomography (PET) for Re-staging of Renal Cell Cancer显示文摘	SAFAEI A FIGLIN R HOH CK	2002	Clin Nephrol2002，57，1：	1
2	Kidney cancer:progress and controversies in neoadjuvant therapy显示文摘	Posadas E M Figlin R A	2014	Nat Rev Urol2014，11，5：	1
3	A phase Ⅱ study of recombinant human interleukin-4 for advanced or recurrent non-small cell lung cancer显示文摘	Figlin R Hochster H	1998	Cancer J Sci Am1998，4，1：	1
4	Q-TWiST analysis to estimate overall benefit for patients with metastatic renal cell carcinoma treated in a phase III trial of sunitinib vs interferon-or显示文摘	PATIL S FIGLIN R A HUTSON T E	2012	Br J Cancer2012，106，15：	1
5	Renal cell carcinoma: recent progress and future directions显示文摘	MuMers P'Figlin R	1997	Cancer Res1997，57，22：	1
6	NCCN Task Force Re- port: mTOR inhibition in solid tumors显示文摘	Figlin R A Brown E Armstrong A J	2008	J Natl Compr Canc Netw2008，6，5：	1
7	Phase I trial of granulocyte macrophage-colony stimulating fac- tor and interleukin-4 as a combined imnmnotherapy for patients with cancer显示文摘	Gitlitz B J Figlin R A Kiertscher S M	2003	J Immunother2003，26，2：	1
8	ABX-EGF, a fully human anti-EGF receptor monoclonal antibody in patients with advanced cancer; phase I clinical results显示文摘	Figlin R A Belldegrum A S Crawford J	2002	Proc Am Soc Clin Oncol2002，21，：	1
9	Phase Ⅰ immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer 显示文摘	ROCHITZ C FIGLIN R SQUIBAN P	2003	J Gene Med2003，5，8：	1
10	A phase Ⅰ trial of CD3/CD28-activated T cells (X cellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma显示文摘	Thompson J A Figlin R A Sifri-Steele C	2003	Clin Cancer Res2003，9，10：	1
11	Targeted therapies for non- small cell lung cancer: an evolving landscape 显示文摘	PAL S K FIGLIN R A RECKAMP K	2010	Mol Cancer Ther2010，9，7：	1
12	Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUCI-positive advanced ctmcer显示文摘	ROCHLITZ C FIGLIN R SQUIBAN P	2003	J Gene Med2003，5，8：	1
13	Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma 显示文摘	Motzer R J Bukowski RM Figlin RA	2008	Cancer2008，113，7：	1
14	: ABX-EGF, a fully human antiepidermal growth factor receptor (EGFR) monoclonal antibody (mAb) in patients with advanced cancer: phase 1 clinical results显示文摘	Figlin R Belldegrun A Crawford J	2002	Proc Am Soc Clin Oncol2002，21，：	1
15	Targeted therapy for sarcomas显示文摘	Forscher C Mita M Figlin R	2014	Biologics2014，8，：	1
16	Treatment of acute rejection in renal graft recipients by thymoglobuline:a retrospective multicenter analysis显示文摘	Taneja SA Figlin R	1995	Transplant Proc1995，27，：	1
17	Renal cell carcinoma: recent progress and future direction显示文摘	Mulders P Figlin R de Kemion JB	1997	Cancer Res1997，57，22：	1
18	Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma 显示文摘	Hudes G Cardueci M Tomczak P Duteher J Figlin R Kapoor A	2007	N Engl J Med2007，356，：	1
19	Renal cell carcinoma: recent progress and future directions显示文摘	MULDERS P FIGLIN R DEKERNION JB	1997	Cancer Res1997，57，：	1
20	Monitoring Cancer Treatment with PET/CT: Does It Make a Difference? 显示文摘	Weber WA Figlin R	2007	J Nucl Med2007，481，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示